Shares of Biogen Inc. BIIB slipped 1.40% to $138.37 Friday, on what proved to be an all-around rough trading session for the ...

The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...

An investment in renewable energy is helping software solutions provider Ideagen shrink its carbon footprint by 30 tonnes of CO2 every year, with a potential five-figure saving on energy bills.

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

Biogen Inc. closed 40.16% below its 52-week high of $238.00, which the company achieved on July 12th.

Biogen Inc. (NASDAQ: BIIB) has unveiled plans for its new global headquarters in Cambridge, located across the Charles River from Boston. The biotechnology company has selected Kendall Common, located ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

It has been about a month since the last earnings report for Biogen Inc. (BIIB). Shares have added about 1.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.

The Chief Executive of The Society of Motor Manufacturers and Traders (SMMT) said that “UK vehicle producers are facing a perfect storm of global trade uncertainty, challenging manufacturing ...

Biogen (BIIB) announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared ...